Future therapeutic targets in mood disorders: The glucocorticoid receptor

British Journal of Psychiatry

Volumn 177, Issue NOV., 2000, Pages 390-395

  McQuade, R ^a   Young, A H ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DESIPRAMINE; FLUOXETINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; IMIPRAMINE; LITHIUM; MAPROTILINE; PRASTERONE; RECEPTOR SUBTYPE;

AFFECTIVE NEUROSIS; COGNITION; DRUG RECEPTOR BINDING; ELECTROCONVULSIVE THERAPY; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEGATIVE FEEDBACK; PATHOGENESIS; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; REVIEW;

ANTIDEPRESSIVE AGENTS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MOOD DISORDERS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; UP-REGULATION;

EID: 0033767639     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.177.5.390     Document Type: Review

References (51)

1. Dexamethasone for the treatment of depression: A randomized, placebo-controlled, double-blind trial
2. Effect of chronic administration of the selective glucocorticoid receptor antagonists ORG 34850, ORG 34116, and ORG 34517 on the rat hypothalamic-pituitary-adrenocortical axis
3. Dehydroepiandrosterone treatment of midlife dysthymia
4. The use of dexamethasone in elderly patients with antidepressant-resistant depressive illness
5. Hippocampal remodeling and damage by corticosteroids: Implications for mood disorders
6. 5-HT(IA) receptor sensitivity in major depression. A neuroendocrine study with buspirone
7. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls
8. Neuropsychological function in euthymic patients with bipolar disorder
9. Three essays on the theory of sexuality
10. Cortisol secretion rate in depressive illness
11. Adrenal steroid secretion and major depression in 8-to 16-year-olds. III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression
12. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
13. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
14. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
15. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis
16. Pharmacology of neural pathways affecting CRH secretion
17. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: Toxicity, immunological, and hormonal aspects
18. The acute effects of corticosteroids on cognition: Integration of animal and human model studies
19. Limited efficacy of ketoconazole in treatment-refractory major depression
20. 5-HT(IA) receptor function in GR transgenic mice
21. Interrelationships between the endocrine system and neuropsychiatry
22. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function
23. Antiglucocorticoid therapies in major depression: A review
24. Possible use of glucocorticoid receptor antagonists in the treatment of major depression: Preliminary results using RU 486
25. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
26. The Role of CRF in the Pathophysiology of Affective Disorders: Laboratory and Clinical Studies
27. Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine
28. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain
29. Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures
30. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment
31. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression
32. The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats
33. The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats
34. Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman
35. The relationship between the effects of metyrapone treatment of depressed mood and urinary steroid profiles
36. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
37. Norepinephrine-independent regulation of GRII mRNA in viva by a tricyclic antidepressant
38. The neuroendocrinology of stress and aging; the glucocorticoid cascade hypothesis
39. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in viva
40. Hypothalamic - Pituitary - Adrenocortical function in mixed and pure mania
41. Decreased glucocorticoid receptor mRNA levels in individuals with depression, bipolar disorder and schizophrenia
42. Models of cognitive impairment: Cognitive changes in depression
43. Chronic corticosterone treatment potentiates deficits following traumatic brain injury in rats: Implications for aging
44. Cognitive effects of corticosteroids
45. Treatment of depression with antiglucocorticoid drugs
46. Double-blind treatment of major depression with dehydroepiandrosterone
47. Antiglucocorticoid treatment of depression: Double-blind ketoconazole
48. The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers
49. Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders
50. Prediction of medium-term outcome by cortisol response rathe combined dexamethasone - CRH test in patients with remitted depression